The Organization of Diabetes Care: Western Pacific Region (China and Hong Kong as Examples)
Juliana C.N. Chan,
Clive S. Cockram,
Juliana C.N. Chan
The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Search for more papers by this authorClive S. Cockram
The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Search for more papers by this authorJuliana C.N. Chan,
Clive S. Cockram,
Juliana C.N. Chan
The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Search for more papers by this authorClive S. Cockram
The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China
Search for more papers by this authorFirst published: 15 October 2003
Abstract
Asia is at the forefront of a global epidemic of diabetes. The region is receiving a double hit from a rising prevalence of young-onset diabetes and from an aging population. The burden of diabetes and its complications threatens to overwhelm health care systems in the region, which contains 25% of the world's population. In this chapter, the need for new approaches and for the evolution of health care delivery from a predominant focus on treatment of acute illnesses to management of chronic diseases and health maintenance are discussed, using Hong Kong and China as examples. The problems are discussed as are some possible solutions that can be applied without major increase in public-funding provision. Collaboration, both multidisciplinary and intersectoral, is emphasized.
References
- 1 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414–31.
- 2 Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782–7.
- 3 Chan JCN, Ng MCY, Critchley JAJH, Lee SC, Cockram CS. Diabetes mellitus—a special medical challenge from a Chinese perspective. Diabetes Res Clin Pract 2001; 54: S19–27.
- 4 Chan JCN, Cockram CS. Diabetes mellitus in Chinese and its implications on health care. Diabetes Care 1997; 20: 1785–90.
- 5 Pan XR, Yang WY, Li GW, Liu J, for the National Diabetes Prevention and Control Cooperative Group. Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 1997; 20: 1664–9.
- 6 Zhong XL. Diabetes mellitus survey in China. Chin Med J 1982; 95: 430–2.
- 7 Cockram CS, Chan JCN. Diabetes in China and Chinese populations. In SM Marshall, PD Home, RA Rizza (eds) The Diabetes Annual 12. The Netherlands: Elsevier, 1999; pp 87–110.
- 8 Baer HA, Singer M, Susser I. The pursuit of health as a human right: health praxis and the struggle for a healthy world. Medical Anthropology and the World System. Westport, CT: Bergin & Garvey, 1997; pp 232–44.
- 9 Dunn F. Traditional Asian medicine and cosmopolitan medicine as adaptive systems. In C Leslie (ed) Asian Medical Systems. A Comparison Study. Berkeley: University of California Press, 1976; pp 133–58.
- 10 Jonsson B. The economic impact of diabetes. Diabetes Care 1998; 21 (suppl 3): C7–10.
- 11 Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastaas M, Salminen V, Uusitupa M, for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343–50.
- 12 Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
- 13 Gaede P, Vedel P, Parving H-H, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999; 353: 617–22.
- 14 Sackett DL, Sharon ES, Richardson WS, Rosenberg W, Haynes RB. Evidence Based Medicine—How to Practice and Teach EBM, 2nd edn. New York: Churchill Livingstone, 2000.
- 15 Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S. Evidence-based disease management. JAMA 1997; 258: 1687–92.
- 16 Quickel KE Jr Diabetes in a managed care system. Ann Intern Med 1996; 124: 160–3.
- 17 Baer HA, Singer M, Susser I. Theoretical perspectives in medical anthropology. Medical Anthropology and the World System. Westport, CT: Bergin & Garvey, 1997; pp 20–36.
- 18 Zgibor JC, Drash AL, Songer TJ, Orchard TJ, Kelsey SF. Influence of health care providers on the development of diabetes complications. Long term follow up from the Pittburgh Epidemiology of Diabetes Complications Study. Diabetes Care 2002; 25: 1584–90.
- 19 So WY, Tong PCY, Ko GTC, Leung WYS, Chow CC, Yeung VTF, Chan WB, Cockram CS, Critchely Julian AJH, Chan JCN. The effects of protocol driven care versus usual outpatient clinic care on survival rates in type 2 diabetic patients. Am J Manag Care 2003; 9: 41–51.
- 20 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Research Group. Retinopathy and nephropathy in patients with Type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381–9.
- 21 National Institute of Diabetes, Digestive and Kidney Disease. Team care: comprehensive lifetime management for diabetes. US National Institute of Health, 2001. Available at: http://ndep.nih.gov/materials/pubs/7-principles/7-english.htm.
- 22 Saaddine JB, Engelgau MM, Beckes GL, Gregg ED, Thompson TJ, Narayan KMV. A Diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002; 136: 565–74.
- 23 Wagner EH, Groves T. Care for chronic diseases. BMJ 2002; 325: 913–4.
- 24 Narayan KMV, Gregg EW, Engelgau MM, Moore B, Thompson TJ, Williamson DF, Vinicor F. Translation research for chronic diseases. The case for diabetes. Diabetes Care 2000; 23: 1794–8.
- 25 Assal J-Ph. Educating the diabetic patient: difficulties encountered by patients and health care providers who have to teach NIDDM and IDDM patients. In C Mogensen, E Standl (eds) Concepts for the Ideal Diabetes Clinic. Berlin: de Gruyter, Walter, 1992; pp 73–87.
- 26 Muhlhauser I, Berger M. Patient education—evaluation of a complex intervention. Diabetologia 2002; 45: 1723–33.
- 27 Sinnock P. Reduced hospital utilization and cost savings associated with diabetes patient education. J Insur Med 1986; 18: 24–30.
- 28 Sinnock P, Bauer DW. Reimbursement issues in diabetes. Diabetes Care 2984; 7: 291–6.
- 29 Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 2002; 25: 324–9.
- 30 Thai AC, and the ASDIAB Study Group. Young Asian Chinese patients with newly diagnosed diabetes mellitus. J Asean Fed Endocr Soc (JAFES) 2000; 18 (suppl 1): 15.
- 31 Quality diabetes care—a model of disease management. In 32nd International Hospital Federation Congress. Hong Kong Exhibition and Convention Centre, 2001. Available at: http://www.hospitalmanagement.net/informer/learning/learning6/index.html.
- 32 Chan JCN, Lau MSW, Wong YM, Chow CC, Yeung VTF, Loo KM, Mong M, Yeung T, Ko GTC, Li KY, So WY, Chan WB, et al. Delivery of diabetes care—the experience at the Prince of Wales Hospital. Hosp Authority Qual Bull 1997; 2: 3–21.
- 33
Lui SF,
Ho YW,
Chau KF,
Leung CB,
Choy BY.
Hong Kong Renal Registry 1995–1999.
Hong Kong J Nephrol
1999;
1:
53–60.
10.1016/S1561-5413(09)60020-X Google Scholar
- 34 Chan JCN, Cheung CK, Cheung MYF, Swaminathan R, Critchley JAJH, Cockram CS. Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM. Diabetes Care 1995; 18: 1013–4.
- 35 Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuizzi G, Snapinin SM, Zhang Z, Shahnifar S, for the RENAAL Study Investigators. Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861–9.
- 36 Leung WYS, So WY, Cockram CS, Critchley JAJH, Chan JCN. The renoprotective effects of intensive care in a clinical trial setting in Type 2 diabetic patients with nephropathy. Diabetes 2001; 50 (suppl 2): A465.
- 37 Leung WYS, So WY, Tong PCY, Ko GTC, Chan JCN. Implementation of a structured care system delayed renal disease progression in Type 2 diabetic patients with nephropathy. Diabetes 2002; 51 (suppl 2): A28.
- 38 Feest TG, Dunn EJ, Burton CJ. Can intensive treatment alter the progress of established diabetic nephropathy to end-stage renal failure? Q J Med 1999; 92: 275–82.
- 39 Schwarzer R. Social–cognitive factors in changing health-related behaviors. Curr Dir Psychol Sci 2001; 10: 47–51.
- 40 Cheah J. Chronic disease management: a Singapore perspective. BMJ 2001; 323: 990–3.
- 41 Plan of Action for the Western Pacific Declaration on Diabetes 2000–2005. Manila: World Health Organization Western Pacific Region, 2001.
